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Abstract Optical coherence tomography (OCT) has been
proven useful in measuring retinal thickness (RT) in
patients with diabetes, although with discordant results in
different studies. We examined RT in patients with type 1
diabetes (T1D) with or without minimal diabetic retinop-
athy (MDR) to test whether OCT is able to identify early
retinal changes and potential correlations with metabolic
parameters. RT of 102 patients with T1D (53 females, 49
males, aged 27.03 ± 7.4 years) and of 42 healthy controls
was examined, with analysis of nine different sectors
(fovea, four pericentral and four peripheral sectors).
According to the results of basal fundus photography,
patients were divided into two groups, without MDR (48
cases) and with MDR (54 cases). Patients with proliferative
DR or macular edema were excluded. No difference was
found between patients with or without MDR and the
control group for all OCT parameters investigated. Mean
HbA1c of the last 5 years (P \ 0.001), microalbuminuria
(P = 0.002), total (P = 0.046) and LDL cholesterol
(P = 0.007) and triglyceride (P \ 0.001) levels were
higher in patients with MDR, along with higher prevalence
of hypertension (P = 0.013), younger age at diagnosis
(P = 0.018) and longer diabetes duration (P \ 0.001) with
regard to the patients without MDR and controls, although
no significant correlation between these parameters and RT
was found. Our study suggests that MDR without macular
edema in patients with T1D cannot be detected with OCT.
Therefore, the conventional diagnostic methods are man-
datory to detect early DR.
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Introduction
Diabetes mellitus is commonly associated with both
microvascular and macrovascular complications increasing
morbidity and reducing life expectancy. There is therefore
more and more interest in identifying diagnostic and ther-
apeutic strategies to reduce or delay the possible onset of
these complications [1, 2]. Diabetic retinopathy (DR), one
of the main causes of blindness in adults, is a relatively
common complication, often causing no symptoms or only
mild vision problems. Recent studies have identified sev-
eral new potential mechanisms to explain the etiopatho-
genesis of pericyte loss or proliferative retinopathy, as the
link between the overexpression of human angiopoietin-2
and the pericyte loss or genetic factors [3, 4]. The diag-
nostic strategies for early detection of DR are of high
priority to avoid or prevent loss of vision in patients with
diabetes. Ophthalmoscopy, fundus photography and, if
necessary, fluorescein angiography are the common tech-
niques used to diagnose DR [5, 6]. Recently, a sensitive,
non-invasive and high-resolution method for examining
ocular tissue, optical coherence tomography (OCT), has
been proposed for early detection of DR; this technique is
able to detect even very small changes in the retinal layers,
therefore improving the diagnosis and management of DR
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[7–9]. In patients with macular edema, it is generally
accepted that OCT is a more sensitive technique for mea-
suring retinal thickness (RT) and volume [10–12], while
the current gold standard for the identification of the
incipient lesions related to subclinical macular edema or
without loss in cells of the retinal layer is fundus photog-
raphy [6]. Several studies have reported OCT-documented
alterations in the RT of patients with diabetes with DR,
although no unanimous results have been obtained [13–16].
Conversely, only a few authors have published data
reporting that OCT is useful in the early stages of DR, as in
the presence of subclinical edema [9, 13]. Both increased
and decreased thickness in different retinal sectors have
been identified in patients with diabetes without clinically
detectable macular edema, and without any correlation
between RT and metabolic parameters. The aim of our
observational study was to determine the variation in OCT-
measured macular thickness in the eyes of selected patients
with type 1 diabetes (T1D) with or without signs of min-
imal DR, in order to detect possible early retinal changes
and to investigate factors that might influence any variation
in macular thickness.
Materials and methods
Patients
The study involved 102 consecutive patients with type 1
diabetes (mean age 27.03 ± 7.4 years), made up of 53
females (52%) and 49 males (48%), observed in our Out-
patients Clinic of Diabetology and Endocrinology Unit
from October 2006 to March 2007. Patients gave their
informed consent according to the guidelines of the Insti-
tutional Review Board at the Faculty of Medicine (Uni-
versity of Palermo). All patients were treated with insulin
basal-bolus therapy (3 short-acting or analog injections
before meals and one long-acting). Clinical and laboratory
parameters were available at diagnosis and then every
3 months, from the beginning of the study. Data included
physical examination, mean value of glycosylated hemo-
globin (HbA1c) during the previous 5 years, lipid profile
(total, HDL and LDL cholesterol, triglycerides), renal
function with serum and urine creatinine and microalbu-
minuria and blood pressure. At the moment of recruitment,
patients were divided into two groups depending on the
results of fundus photography, those without retinal alter-
ations (group A, 48 cases) and those with minimal diabetic
retinopathy (MDR) with no evidence of clinically signifi-
cant macular edema (CSME) (group B, 54 cases). MDR
was defined as the presence of at least two microaneurysms
and/or minor hemorrhages in the central retina [17]. A
healthy control group was included (group C, 42 cases),
age and gender matched, with no family history of ocular
disease, glaucoma or any relevant systemic disease.
CSME is defined as retinal thickening within 500 lm of
the center of the macula or, alternatively, hard exudates
within 500 lm from the center of the macula with thick-
ening of the adjacent retina, in accordance with ETDRS)
[18] .
OCT measurements
Quantitative assessment of retinal thickness was performed
with Stratus OCT-Model 3000 (Carl Zeiss Meditec, Dublin,
CA, USA), using the fast macular thickness OCT scan
protocol. Briefly, retinal thickness was calculated in 3
areas: fovea (central circle, with a diameter of 1 mm),
pericentral area (shaped ring comprised between an inner
diameter of 1 mm and an outer diameter of 3 mm) and
peripheral or paracentral area (inner diameter of 3 mm and
outer diameter of 6 mm). Fast macular thickness scan
protocol was performed in both eyes in all subjects and the
same expert examiners obtained OCT scans for each eye.
Statistical analysis
Statistical analyses were performed using SPSS for Win-
dows (2001 release 11.0, Chicago, USA). Continuous
variables were analyzed as mean values ± standard devi-
ation (SD). Rates and proportions were calculated for
categorical data. For categorical variables, differences were
analyzed with v2 test and Fisher’s exact test when appro-
priate. Differences among continuous variables with nor-
mal distribution were analyzed by Student’s T-test; for
continuous variables without normal distribution, we used
non-parametric tests and differences were analyzed by the
Mann–Whitney U-test. Differences among the three groups
(control subjects, group A and group B) were analyzed
with Univariate ANOVA and Bonferroni post hoc test.
Correlations among RT and metabolic parameters were
determined by using Pearson’s test. P value of \0.05 was
considered statistically significant.
Results
Table 1 shows the features of the patients with diabetes
subdivided according to the results of the fundus exami-
nation at the time of recruitment. There was no significant
difference in age and sex between group A and B, whereas
in group B the age at the time of diagnosis of T1D was
lower than in group A (P \ 0.01). Patients with minimal
DR (group B) had a higher disease duration compared with
group A as well as higher HbA1c levels (P \ 0.001). The
difference in HbA1c levels was found not only at the time
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of OCT analysis but also during the previous 5 years, as
shown in the clinical records (mean values calculated as
average of values recorded every trimester). A higher
prevalence of hypertension and higher total cholesterol,
LDL, triglyceride and microalbuminuria levels were
observed in group B in comparison with group A, con-
firming that group B had less metabolic control. A linear
correlation showed that two retinal areas significantly
correlated with metabolic parameters; in fact, the thickness
of the right peripheral area significantly correlated with
HbA1c at the time of the study (r = 0.424, P = 0.009) and
with HbA1c mean values of the previous 5 years (r =
0.406, P = 0.013) while the thickness of the right peri-
central area correlated with microalbuminuria (r = 0.382,
P = 0.020). No correlation was found for other retinal
areas. Furthermore, when we compared RT mean values of
groups A, B and the age-matched control subjects, no
significant difference was detected for any of the parame-
ters examined (Table 2).
Discussion
Diabetic complications, including diabetic retinopathy,
have long been the subject of studies aimed at identifying
clear etiopathogenetic factors with diagnostic and thera-
peutic implications [3, 4]. OCT is currently considered an
important biomedical imaging tool for high-resolution ret-
inal evaluation, but without unanimous data in the absence
of clinically detectable macular edema [9, 13]. In our study,
we investigated whether OCT is able to detect early
impairment of diabetic retinal thickness in patients with
Table 1 Features of patients with type 1 diabetes without (NDR) and with minimal diabetic retinopathy (MDR)
Group A
(NDR)
No. 48
Group B
(MDR)
No. 54
P
A vs. B
Age (years), Mean (SD) 25.88 (7.24) 29.15 (7.61) 0.189§
Diabetes onset age, Mean (SD) 19.62 (7.64) 13.61 (6.58) 0.018*
Gender
M, No. (%) 25 (52) 24 (44.5) 0.567
F, No. (%) 23 (48) 30 (55.5)
Duration of diabetes (years), Mean (SD) 6.25 (5.69) 15.53 (3.73) \0.001*
HbA1c (at the time of OCT) (%), Mean (SD) 7.6 (1.6) 10.6 (2.65) \0.001§
Mean HbA1c (of the last 5 years) (%), Mean (SD) 7.5 (1.22) 9.9 (1.4) \0.001*
Hypertension, No. (%) 2 (8.33) 6 (46.15) 0.013
Total cholesterol (mmol/l), Mean (SD) 4.28 (0.98) 5.05 (0.53) 0.004*
HDL cholesterol (mmol/l), Mean (SD) 1.57 (0.47) 1.33 (0.40) 0.119*
LDL cholesterol (mmol/l), Mean (SD) 2.24 (0.99) 2.96 (0.44) 0.003*
Triglycerides (mmol/l), Mean (SD) 1.01 (0.40) 1.65 (0.33) \0.001*
Microalbuminuria (mg/l), Mean (SD) 4.69 (6.49) 127.57 (271.37) 0.002§
* Student’s T-test; § Mann–Whitney test
Table 2 Retinal thickness (RT) values (expressed as lm) in patients with diabetes and control subjects
Group A
(NDR)
No. 48
Group B
(MDR)
No. 54
Group C
(Control)
No. 42
P*
A vs. B
P*
A vs. C
P*
B vs. C
Mean SD Mean SD Mean SD
Fovea (right) 206.5 21.3 206 23.5 201.1 18.9 1 1 1
Fovea (left) 206.1 19.9 207.9 26.9 199.6 18.7 1 0.770 0.702
Pericentral (right) 267.6 13.1 274.4 26.6 271.6 15.5 0.786 1 1
Pericentral (left) 269.7 12.7 275.2 19.6 271.8 13.5 0.823 1 1
Peripheral (right) 241.8 12.3 253 22.7 240.5 13.1 0.109 1 0.046
Peripheral (left) 242.5 15.8 243.9 16.8 241.2 13.5 1 1 1
* Bonferroni post hoc test
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T1D with no signs of retinopathy and in patients with
minimal retinopathy, without macular edema, in compari-
son with healthy subjects. Several studies have reported that
OCT provides important information about the retina of
patients with diabetes. The majority of clinical studies have
been performed on heterogeneous groups of patients, with
macular edema and/or including patients with type 2 dia-
betes [19, 20]. In our opinion, the strength of this study lies
is the careful selection of patients, with the exclusive
inclusion of patients with type 1 diabetes mellitus and the
exclusion of patients with macular edema or proliferative
retinopathy. It is in fact generally accepted that OCT is the
technique of choice for understanding the anatomy of
macular edema [10] but also in the absence of the latter,
both increased and decreased thicknesses in different retinal
sectors have been shown in different studies. Biallosterski
et al. demonstrated significantly decreased RT, but only in
pericentral sectors, in patients with T1D with minimal DR
compared to healthy controls, assuming a loss of intraretinal
neural tissue in the earlier stage of DR, while no difference
was detected in the remaining areas [16]. Conversely,
Lattanzio et al. showed increased macular thickness in
patients with diabetes according to the progression of DR
and the presence of macular edema, thus considering OCT a
sensitive technique for early detection of diabetic macular
abnormalities [20]. In our study, RT in patients with T1D
with minimal or no retinopathy is not significantly different
from that of the control group. This is consistent with pre-
vious reports [21]. Furthermore, OCT-measured RT and its
relationship with metabolic factors in patients with T1D
have also been assessed. Recently, a correlation was
reported between macular thickness and HbA1c values, but
only in type 2 diabetes [22], while in this study only two
retinal areas (peripheral and pericentral right areas) signif-
icantly correlate with metabolic parameters, HbA1c and
microalbuminuria levels, respectively. In conclusion, our
data confirm that duration of type 1 diabetes, lipid values,
hypertension, microalbuminuria and HbA1c levels (con-
sidered both at the time of OCT evaluation and as mean
values of the previous 5 years) are the most relevant factors
for DR. This study suggests that there is no advantage in
performing OCT routinely in patients with T1D without or
with MDR in the absence of macular edema. Therefore, we
conclude that screening of early DR should be performed by
well-recognized conventional methods.
References
1. Giugliano D, Standl E, Vilsbøll T, Betteridge J, Bonadonna R,
Campbell IW, Schernthaner GH, Staels B, Trichopoulou A,
Farinaro E (2009) Is the current therapeutic armamentarium in
diabetes enough to control the epidemic and its consequences?
What are the current shortcomings? Acta Diabetol 46(3):173–181
2. Cerbone AM, Macarone-Palmieri N, Saldalamacchia G, Coppola
A, Di Minno G, Rivellese AA (2009) Diabetes, vascular com-
plications and antiplatelet therapy: open problems. Acta Diabetol
46(4):253–261
3. Pfister F, Wang Y, Schreiter K, Vom Hagen F, Altvater K,
Hoffmann S, Deutsch U, Hammes HP, Feng Y (2010) Retinal
overexpression of angiopoietin-2 mimics diabetic retinopathy and
enhances vascular damages in hyperglycemia. Acta Diabetol
47(1):59–64
4. Djuric Z, Sharei V, Rudofsky G, Morcos M, Li H, Hammes HP,
Nawroth PP, Bierhaus A, Humpert PM, Jonas JB (2010) Asso-
ciation of homozygous SDF-1 3’A genotype with proliferative
diabetic retinopathy. Acta Diabetol 47(1):79–82
5. Moss SE, Klein R, Kessler SD, Richie KA (1985) Comparison
between ophthalmoscopy and fundus photography in determining
severity of diabetic retinopathy. Ophthalmology 92(1):62–67
6. McIntosh A, Peters J, O’Keeffe C, Khunti K, Baker R, Booth A
(2000) Effectiveness of screening and monitoring tests for dia-
betic retinopathy a systematic review. Diabet Med 17(7):495–506
7. Lang GE (2007) Optical coherence tomography findings in dia-
betic retinopathy. Dev Ophthalmol 39:31–47
8. Baumal CR (1999) Clinical applications of optical coherence
tomography. Curr Opin Ophthalmol 10:182–188
9. Schaudig UH, Glaefke C, Scholz F, Richard G (2000) Optical
coherence tomography for retinal thickness measurement in
diabetic patients without clinically significant macular edema.
Ophthalmic Surg Lasers 31(3):182–186
10. Panozzo G, Gusson E, Parolini B, Mercanti A (2003) Role of
OCT in the diagnosis and follow up of diabetic macular edema.
Semin Ophthalmol 18(2):74–81
11. Alkuraya H, Kangave D, Abu El-Asrar AM (2005) The correla-
tion between optical coherence tomographic features and severity
of retinopathy, macular thickness and visual acuity in diabetic
macular edema. Int Ophthalmol 26(3):93–99
12. Hee MR, Puliafito CA, Duker JS, Reichel E, Coker JG, Wilkins
JR, Schuman JS, Swanson EA, Fujimoto JG (1998) Topography
of diabetic macular edema with optical coherence tomography.
Ophthalmology 105(2):360–370
13. Browning DJ, Fraser CM, Clark S (2008) The relationship of
macular thickness to clinically graded diabetic retinopathy
severity in eyes without clinically detected diabetic macular
edema. Ophthalmology 115(3):533–539
14. Pires I, Bernardes RC, Lobo CL, Soares MA, Cunha-Vaz JG
(2002) Retinal thickness in eyes with mild nonproliferative reti-
nopathy in patients with Type 2 diabetes mellitus. Comparison of
measurements obtained by retinal thickness analysis and optical
coherence tomography. Arch Ophthalmol 120(10):1301–1306
15. Massin P, Erginay A, Haouchine B, Mehidi AB, Paques M,
Gaudric A (2002) Retinal thickness in healthy and diabetic sub-
jects measured using optical coherence tomography mapping
software. Eur J Ophthalmol 12(2):102–108
16. Biallosterski C, Van Velthoven ME, Michels RP, Schlingemann
RO, Devries JH, Verbraak FD (2007) Decreased optical coher-
ence tomography-measured pericentral retinal thickness in
patients with diabetes mellitus type 1 with minimal diabetic ret-
inopathy. Br J Ophthalmol 91(9):1135–1138
17. Early Treatment Diabetic Retinopathy Study Research Group
(1991) Grading diabetic retinopathy from stereoscopic color
fundus photographs—an extension of the modified Airlie House
classification. ETDRS Report Number 10. Ophthalmology
98:786–806
18. Early Treatment Diabetic Retinopathy Study Research Group
(1985) Photocoagulation treatment for Diabetic Macular Edema.
ETDRS Report Number 1. Arch Ophthalmol 103:1796–1806
262 Acta Diabetol (2010) 47:259–263
123
19. Goebel W, Kretzchmar-Gross T (2002) Retinal thickness in
diabetic retinopathy—a study using optical coherence tomogra-
phy. Retina 22:759–767
20. Lattanzio R, Brancato R, Pierro L, Bandello F, Iaccher B, Fiore
T, Maestranzi G (2002) Macular thickness measured by optical
coherence tomography (OCT) in diabetic patients. Eur J Oph-
thalmol 12(6):482–487
21. Bressler NM, Edwards AR, Antoszyk AN, Beck EW, Browning
DJ, Ciardella AP, Danis RP, Elman MJ, Friedman SM, Glassman
AR, Gross JG, Li HK, Murtha TJ, Stone TW, Sun JK, Diabetic
Retinopathy Clinical Research Network (2008) Retinal thickness
on Stratus optical coherence tomography in people with diabetes
and minimal or no diabetic retinopathy. Am J Ophthalmol 145(5):
894–901. Epub 2008 Feb 21
22. Chou TH, Wu PC, Kuo JZ, Lai CH, Kuo CN (2009) Relationship
of diabetic macular oedema with glycosylated haemoglobin. Eye
23(6):1360–1363
Acta Diabetol (2010) 47:259–263 263
123
